Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2021 Earnings Conference Call March 10, 2022 4:30 PM ET
Company Participants
Richard Miller - Co-Founder, President and CEO
Leiv Lea - CFO
Zack Kubow - Investor Relations, Real Chemistry
Conference Call Participants
Li Watsek - Cantor Fitzgerald
Mara Goldstein - Mizuho
Roger Song - Jefferies.
Arthur He - H.C. Wainwright
Operator
Greetings. Welcome to Corvus Pharmaceuticals Fourth Quarter 2021 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded.
I will now turn the conference over to Zack Kubow of Real Chemistry. Thank you. You may begin.
Zack Kubow
Thank you, operator, and good afternoon, everyone. Thanks for joining us for the Corvus Pharmaceuticals fourth quarter 2021 business update and financial results conference call. On the call to discuss the results and business updates are Richard Miller, Chief Executive Officer; and Leiv Lea, Chief Financial Officer. The executive team will open the call with some prepared remarks followed by a question-and-answer period.
I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Forward-looking statements are based on estimates and assumptions as of today and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by those statements, including the risks and uncertainties described in Corvus’ Annual Report on Form 10-K, which was filed today with the SEC and other filings the company makes with the SEC from time to time. The company undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.
With that, I’d like to turn the call over to Leiv Lea. Leiv?
Leiv Lea
Thank you, Zack. I will begin with a quick overview of our fourth quarter and full year 2021 financials and then turn
- Read more current CRVS analysis and news
- View all earnings call transcripts